Leukemia Clinical Trials

Showing 4721-4740 of 8,366 trials

Micronutrient Supplementation Before and During 1st Pregnancy to Improve Birth Outcomes (JiVitA-5)

NCT03921177

The purpose of this cluster-randomized trial is to evaluate the efficacy of daily, multiple micronutrient (MM) supplement versus identical placebo use among nulligravid, recently married women, starting preconceptionally through the 1st trimester of pregnancy, in reducing low birth weight and other adverse pregnancy outcomes in rural Bangladesh.

Birth WeightMiscarriageSmall-for-gestational Age+1 more

Johns Hopkins Bloomberg School of Public Health9,859 participantsStarted Jan 2019

Gaibandha, Gaibandha Distict, Bangladesh

COMPLETEDNA

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

NCT04913714

A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness

Infant ALL

Syracuse University1,320 participantsStarted Oct 2020

Syracuse, New York, United States • Jimma, Ethiopia

UNKNOWNPhase 2

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT01894477

This randomized phase II trial studies how well treosulfan and fludarabine phosphate, with or without total body irradiation before donor stem cell transplant works in treating patients with myelodysplastic syndrome or acute myeloid leukemia. Giving chemotherapy, such as treosulfan and fludarabine phosphate, and total-body irradiation before a donor stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells. The donated stem cells may replace the patient's immune cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body's normal cells. Giving tacrolimus before and mycophenolate mofetil after the transplant may stop this from happening.

Acute Myeloid Leukemia in RemissionChronic Myelomonocytic LeukemiaMinimal Residual Disease+3 more

Fred Hutchinson Cancer Center102 participantsStarted Nov 2013

Seattle, Washington, United States

Micronutrient Supplementation Before and During 1st Pregnancy to Improve Birth Outcomes (JiVitA-5)

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Related Searches

Osimertinib Study in Indian Patients

CD19-Specific T Cells Post AlloSCT

Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia

Combined Exercise and Cognitive Stimulation for Falls Prevention

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.

Locally Advanced NSCLC Hyperfractionated RT

Hypnosis Versus General Anesthesia in Pediatric Surgery: Clinical and Medico-economic Interests

PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC

Environmental Pollutants and Their Effects on Respiratory Allergy

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Effect of Intralymphatic Immunotherapy

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Allergology: Information, Data and Knowledge Organization

First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)